$ABBV Recent News Yet again, Dow, S&P 500 notch new

New Post Public Reply Private Reply Replies (0) Message Board

Jun 22, 2014 at 2:20 PM

$ABBV Recent News

Yet again, Dow, S&P 500 notch new records 4:44 p.m. June 20, 2014 - Victor Reklaitis
Oracle slides on disappointing results; CarMax soars 4:16 p.m. June 20, 2014 - Ben Eisen
Shire boosts FTSE 100 to fourth day in black 12:37 p.m. June 20, 2014 - Sara Sjolin
European stocks lose steam after consumer data 12:09 p.m. June 20, 2014 - Sara Sjolin
AbbVie fails to woo Shire, but investors think someone can do it 11:10 a.m. June 20, 2014 - blogs.marketwatch.com
Newscast: A drug merger is on hold 10:04 a.m. June 20, 2014 - MarketWatch
Stock futures seesaw, but indexes eye weekly gains 8:04 a.m. June 20, 2014 - Carla Mozee
Newscast: A drug merger isn't happening right now 7:39 a.m. June 20, 2014 - MarketWatch
Shire rebuffs $46 billion takeover bid from AbbVie 3:29 a.m. June 20, 2014 - WSJ Staff
Rival to Gilead's pricey Sovaldi expected to hit market later this year 7:28 a.m. June 18, 2014 - blogs.marketwatch.com
E-Trade, Schwab up on HFT hearing; Tesla extends gains 3:53 p.m. June 17, 2014 - Ben Eisen
Microsoft, Amazon, Starbucks are stocks to watch 8:46 a.m. April 25, 2014 - Sue Chang
AbbVie shares rise after earnings top forecasts 8:10 a.m. April 25, 2014 - Ben Eisen
AbbVie shares rise 2.4% premarket on earnings 8:03 a.m. April 25, 2014 - Ben Eisen
Abbvie Q1 EPS tops forecast of $0.68 8:02 a.m. April 25, 2014 - Ben Eisen
AbbVie reaffirms 2014 adj EPS range of $3 to $3.10 8:00 a.m. April 25, 2014 - Ben Eisen
AbbVie Q1 sales rise to $4.56 bln vs $4.33 bln 7:59 a.m. April 25, 2014 - Ben Eisen
AbbVie Q1 EPS edges up to $0.61; Adjusted: $0.71 7:59 a.m. April 25, 2014 - Ben Eisen
AbbVie Q1 profit rises to $980 mln vs $968 mln 7:59 a.m. April 25, 2014 - Ben Eisen
I have no qualms about taking Gilead’s $84,000 drug 7:30 a.m. April 22, 2014 - Tim Mullaney

Dow, S&P 500 End at Records 7:33 p.m. June 20, 2014 - The Wall Street Journal Interactive Edition
Inversion Frenzy Rocks Drug Sector 7:28 p.m. June 20, 2014 - The Wall Street Journal Interactive Edition
Growth Stocks Kick Into Gear In Latest IBD 50 Screen 5:35 p.m. June 20, 2014 - Investors Business Daily
Just a Regular Day of Record Highs, No Big Deal 4:21 p.m. June 20, 2014 - TheStreet.com
European Investors Seek Safety 12:13 p.m. June 20, 2014 - The Wall Street Journal Interactive Edition
Stocks Rise as S&P 500 Extends Record High 12:07 p.m. June 20, 2014 - TheStreet.com
Achillion Could Win Idenix's Mystery Suitor: Analyst 11:44 a.m. June 20, 2014 - Investors Business Daily
Shire Rejects AbbVie's $46 Bil Tax-Inversion Attempt 10:41 a.m. June 20, 2014 - Investors Business Daily
AbbVie Needs More to Land Shire 10:20 a.m. June 20, 2014 - The Wall Street Journal Interactive Edition
AbbVie (ABBV) Is Today's Water-Logged And Getting Wetter Stock 9:52 a.m. June 20, 2014 - TheStreet.com
Shire Rejects $46B AbbVie Offer 9:40 a.m. June 20, 2014 - TheStreet.com
Stock Futures Trade Flat as Iraq Troubles Weigh 8:27 a.m. June 20, 2014 - TheStreet.com
Why Shire (SHPG) Stock Is Soaring This Morning 8:11 a.m. June 20, 2014 - TheStreet.com
AbbVie - Attempt To Acquire Shire Is Driven By Opportunistic Tax Synergies 7:34 a.m. June 20, 2014 - Seeking Alpha
More on AbbVie's pursuit of Shire 7:06 a.m. June 20, 2014 - Seeking Alpha
June 20 Premarket Briefing: 10 Things You Should Know 6:47 a.m. June 20, 2014 - TheStreet.com
European Stocks Lose Momentum but Remain Higher 6:37 a.m. June 20, 2014 - TheStreet.com
Wall Street Breakfast: Ukraine Tensions, Bank Settlements, Siemens Bid 6:33 a.m. June 20, 2014 - Seeking Alpha
Shire rejects AbbVie merger 2:31 a.m. June 20, 2014 - Seeking Alpha
Fire Up The Immuno-Oncology Powerhouses: John McCamant 5:39 p.m. June 19, 2014 - Seeking Alpha

NDA Resubmission, Accelerated Assessment of Marketing Application, and Esteemed Recognition - Analyst Notes on McKesson, AbbVie, Lilly, Zoetis and Salix 5:00 a.m. June 20, 2014 - PR Newswire - PRF
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 11:48 p.m. June 19, 2014 - PR Newswire - PRF
AbbVie Declares Quarterly Dividend 11:28 a.m. June 19, 2014 - PR Newswire - PRF
European Medicines Agency Validates Marketing Authorization Applications for AbbVie's Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 1 Chronic Hepatitis C 2:00 a.m. June 17, 2014 - PR Newswire - PRF
Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple Sclerosis 7:30 a.m. June 16, 2014 - BusinessWire - BZX
U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 1 Chronic Hepatitis C 3:34 p.m. June 13, 2014 - PR Newswire - PRF
Equity Coverage on Pharma Industry -- Research on AbbVie, AcelRx Pharma, Bristol-Myers Squibb, and GW Pharma 7:10 a.m. June 13, 2014 - PR Newswire - PRF
Expansions, New Leadership, Annual Award Winners, FDA Approvals, and Abstracts Presentations - Analyst Notes on AbbVie, Amgen, Regeneron Pharmaceuticals Inc, Valeant Pharmaceuticals and Lilly 6:40 a.m. June 12, 2014 - PR Newswire - PRF
AbbVie Presents Results from Large Global Study of Patient Attitudes and Adherence Across Six Chronic Inflammatory Diseases 2:00 a.m. June 11, 2014 - PR Newswire - PRF
AbbVie to Present at Goldman Sachs 35th Annual Global Healthcare Conference 8:00 a.m. June 10, 2014 - PR Newswire - PRF
AbbVie to Present at Jefferies 2014 Global Healthcare Conference 8:30 a.m. June 3, 2014 - PR Newswire - PRF
AbbVie Presents New Results from Studies of Investigational Oncology Compound ABT-199/GDC-0199 at the 2014 American Society of Clinical Oncology Annual Meeting 8:00 a.m. May 31, 2014 - PR Newswire - PRF
AbbVie Presents Results from Study of Investigational Compound in Patients with Glioblastoma at the American Society of Clinical Oncology's 50th Annual Meeting 8:00 a.m. May 30, 2014 - PR Newswire - PRF
Secondary Offering, Appointments, and Clinical Developments - Analyst Notes on HCA, Biogen Idec, WellPoint, AbbVie and Mylan 7:00 a.m. May 23, 2014 - PR Newswire - PRF
Study Results, Extension of Supply Agreements, Drug Designations, Senior Level Appointments, and Upcoming Events - Analyst Notes on InterMune, Actavis, Bristol-Myers, AbbVie and Illumina 8:30 a.m. May 22, 2014 - PR Newswire - PRF
Morning Analysis on Active Equities -- Research on AbbVie, Johnson Controls, DISH, and CEMEX 8:50 a.m. May 20, 2014 - PR Newswire - PRF
AbbVie to Present at 2014 UBS Global Healthcare Conference 8:00 a.m. May 20, 2014 - PR Newswire - PRF
AbbVie Announces Michael Severino, M.D. to Lead R&D Organization and Drive Continued Pipeline Advancement 12:00 p.m. May 15, 2014 - PR Newswire - PRF
Marketing Authorization Applications, Clinical Trial Results, Awards & Recognitions, and Resources Expansions - Analyst Notes on AbbVie, Medtronic, Abbott, Zimmer and Arena 8:40 a.m. May 15, 2014 - PR Newswire - PRF
Agreements, Earnings Releases, Senior-Level Retirements and Appointments, and Marketing Authorizations - Analyst Notes on Actavis, Jazz Pharmaceuticals, Bristol-Myers, Biogen Idec and AbbVie 7:00 a.m. May 14, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Push Notification Security Transforms Healthcare IT Support

Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...

Tampa General’s Innovation Excellence Earns No. 20 Spot

A Bold Leap into Innovation at Tampa General There's a heck of a lot going on down in Tampa that's worth more than just a golf clap. Tampa General Hospital (TGH) just snagged the 20th spot on Fast Company's Best Workplaces for Innovators list, and let me tell you, that’s no small feat amidst the heavy hitters in verticals like biotech and consumer goods. It takes guts...

RevSystems Joins Elite OpenAI Partner Network

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...

Facility Solutions Group Climbs to Top 18 Electrical Spot

FSG Shines Brightly in Electrical Contractor Rankings Climbing the ladder is no easy feat, but Facility Solutions Group (FSG) has managed to climb, all the way to the #18 spot on Electrical Construction & Maintenance (EC&M) magazine's revered list of the Top Electrical Contractors in the U.S. It’s up from their previous rank of 22. When you think about the competitive...

From Kitchen Experiment to U.S. Debut Here's a story that barely fits the tight mold of your typical business textbook. Hair Syrup, born from the brain of a university student tinkering at her kitchen table, is about to make waves across the pond. Lucie Macleod did what many dream of—she took a DIY hair oil project and spun it into a multimillion-dollar brand, now set...

Shareholder Rights in Focus: Examining Key Buyouts

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Health Net's $2M Boost for Stanislaus Affordable Housing

Joining the Fight Against California’s Housing Crisis Well, I'll be the first to say it's a breath of fresh air when a healthcare beast like Health Net starts investing in something as critical as affordable housing. This is no drop in the bucket—two million dollars is quite the commitment to fix some of the mess that’s been brewing in Stanislaus County, California....

Wave Kids™ Unveils New Flavors for Kids' Drinks

Sparking a Fresh Wave in the Kids' Beverage Market Alright, let me tell you about a new player plowing into the kids' drink scene. Wave Kids™, a brand that's making waves—pun intended—has a fresh lineup that screams 'fun' and 'healthy' in equal measure. Just coinciding with back-to-school season, this Scottsdale, Arizona outfit has rolled out not one or two, but...

Sacrifice Unending: 9/11's Lingering Health Toll

The Unseen Toll of 9/11 on the Firefighter Community Two and a half decades since that fateful morning of September 11, 2001, we're staring at a grim reality. The heroic souls of the New York City Fire Department (FDNY)—those who ran toward peril when others ran away—are still paying the price. Incredibly, more than 400 FDNY members have succumbed to World Trade...

Monib Zirvi's Dermatology Excellence Honored in 2026

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...